Gene Expression Analysis Reveals a Subset of TP53mutant-like AML with Wild Type TP53 and Poor Prognosis

被引:0
|
作者
Lee, Yoonkyu [1 ,2 ,3 ]
Myers, Chad [2 ,4 ,5 ]
Sachs, Zohar [1 ,2 ,5 ]
机构
[1] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN USA
[2] Univ Minnesota, Bioinformat & Computat Biol Program, Rochester, MN USA
[3] Univ Minnesota, Minneapolis, MN USA
[4] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA
[5] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
关键词
D O I
10.1182/blood-2022-167021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:9108 / 9109
页数:2
相关论文
共 50 条
  • [41] Evaluation of Sirtuins and TP53 Gene Expression and Their Impact on Prognosis in Acute Myeloid Leukemia
    Strzalka, Piotr
    Krawiec, Kinga
    Jarych, Dariusz
    Wisnik, Aneta
    Goralska, Magdalena
    Soin, Michal
    Mikulski, Damian
    Czemerska, Magdalena
    Zawlik, Izabela
    Pluta, Agnieszka
    Wierzbowska, Agnieszka
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S314 - S315
  • [42] How wild-type TP53 is inactivated in undifferentiated-type gastric carcinomas:: Analyses of intratumoral heterogeneity in deletion and mutation of TP53
    Yoshimura, Akinobu
    Sugihara, Hiroyuki
    Ling, Zhi-Qiang
    Peng, Dun-Fa
    Mukaisho, Ken-ichi
    Fujiyama, Yoshihide
    Hattori, Takanori
    PATHOBIOLOGY, 2006, 73 (01) : 40 - 49
  • [43] Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients
    Ferrari, Anna
    Fonzi, Eugenio
    Fontana, Maria Chiara
    Di Rora, Andrea Ghelli Luserna
    Manfrini, Marco
    Padella, Antonella
    Baldazzi, Carmen
    Papayannidis, Cristina
    Marconi, Giovanni
    Paolini, Stefania
    Guadagnuolo, Viviana
    Perricone, Margherita
    Robustelli, Valentina
    Imbrogno, Enrica
    Franchini, Eugenia
    Venturi, Claudia
    Zuffa, Elisa
    Abbenante, Maria Chiara
    Simonetti, Giorgia
    Testoni, Nicoletta
    Ottaviani, Emanuela
    Giovanni, Martinelli
    CANCER RESEARCH, 2017, 77
  • [44] Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma
    Chen, Yu-Jen
    Hakin-Smith, Vicky
    Teo, Mario
    Xinarianos, George E.
    Jellinek, David A.
    Carroll, Thomas
    McDowell, David
    MacFarlane, Martin R.
    Boet, Ronald
    Baguley, Bruce C.
    Braithwaite, Antony W.
    Reddel, Roger R.
    Royds, Janice A.
    CANCER RESEARCH, 2006, 66 (13) : 6473 - 6476
  • [45] Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
    Peng, Jianbo
    Fang, Shuo
    Li, Meisheng
    Liu, Yuxin
    Liang, Xiaolu
    Li, Zuobiao
    Chen, Gaohui
    Peng, Lijiao
    Chen, Nianping
    Liu, Lei
    Xu, Xiaohong
    Dai, Wei
    OPEN LIFE SCIENCES, 2023, 18 (01):
  • [46] Molecular and genetic determinants of dysfunctional wild type TP53 in glioblastoma
    Zhao, Y.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S27 - S28
  • [47] CRISPR screens are feasible in TP53 wild-type cells
    Brown, Kevin R.
    Mair, Barbara
    Soste, Martin
    Moffat, Jason
    MOLECULAR SYSTEMS BIOLOGY, 2019, 15 (08)
  • [48] Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53
    Yoon, H
    Liyanarachchi, S
    Wright, FA
    Davuluri, R
    Lockman, JC
    de la Chapelle, A
    Pellegata, NS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) : 15632 - 15637
  • [49] Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53-associated features
    Benor, Gal
    Fuks, Garold
    Chin, Suet-Feung
    Rueda, Oscar M.
    Mukherjee, Saptaparna
    Arandkar, Sharathchandra
    Aylon, Yael
    Caldas, Carlos
    Domany, Eytan
    Oren, Moshe
    MOLECULAR ONCOLOGY, 2020, 14 (08) : 1640 - 1652
  • [50] TP53 status and impact on AML prognosis within the ELN 2022 risk classification
    Fleming, Shaun
    Tsai, Xavier Cheng-Hong
    Morris, Rhiannon
    Hou, Hsin-An
    Wei, Andrew H.
    BLOOD, 2023, 142 (23) : 2029 - 2033